230 related articles for article (PubMed ID: 26903367)
41. What do we know about the reduction of Pt(IV) pro-drugs?
Wexselblatt E; Gibson D
J Inorg Biochem; 2012 Dec; 117():220-9. PubMed ID: 22877926
[TBL] [Abstract][Full Text] [Related]
42. Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes.
Ermondi G; Caron G; Ravera M; Gabano E; Bianco S; Platts JA; Osella D
Dalton Trans; 2013 Mar; 42(10):3482-9. PubMed ID: 23263457
[TBL] [Abstract][Full Text] [Related]
43. A (salicylaldiminato)Pt(II) complex with dimethylpropylene linkage: Synthesis, structural characterization and antineoplastic activity.
Azam M; Al-Resayes SI; Soliman SM; Trzesowska-Kruszynska A; Kruszynski R; Khan Z
J Photochem Photobiol B; 2017 Nov; 176():150-156. PubMed ID: 29024872
[TBL] [Abstract][Full Text] [Related]
44. Pt(II) complexes with (N,N') or (C,N,E)(-) (E=N,S) ligands: cytotoxic studies, effect on DNA tertiary structure and structure-activity relationships.
Albert J; Bosque R; Crespo M; Granell J; López C; Cortés R; Gonzalez A; Quirante J; Calvis C; Messeguer R; Baldomà L; Badia J; Cascante M
Bioorg Med Chem; 2013 Jul; 21(14):4210-7. PubMed ID: 23735827
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
Lazić JM; Vucićević L; Grgurić-Sipka S; Janjetović K; Kaluderović GN; Misirkić M; Gruden-Pavlović M; Popadić D; Paschke R; Trajković V; Sabo TJ
ChemMedChem; 2010 Jun; 5(6):881-9. PubMed ID: 20408161
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin.
Ravera M; Gabano E; Zanellato I; Bonarrigo I; Escribano E; Moreno V; Font-Bardia M; Calvet T; Osella D
Dalton Trans; 2012 Mar; 41(11):3313-20. PubMed ID: 22286213
[TBL] [Abstract][Full Text] [Related]
48. Syntheses, characterization, and antitumor activities of platinum(II) and palladium(II) complexes with sugar-conjugated triazole ligands.
Yano S; Ohi H; Ashizaki M; Obata M; Mikata Y; Tanaka R; Nishioka T; Kinoshita I; Sugai Y; Okura I; Ogura S; Czaplewska JA; Gottschaldt M; Schubert US; Funabiki T; Morimoto K; Nakai M
Chem Biodivers; 2012 Sep; 9(9):1903-15. PubMed ID: 22976979
[TBL] [Abstract][Full Text] [Related]
49. New 7-azaindole palladium and platinum complexes: crystal structures and theoretical calculations. In vitro anticancer activity of the platinum compounds.
Ruiz J; Rodríguez V; de Haro C; Espinosa A; Pérez J; Janiak C
Dalton Trans; 2010 Apr; 39(13):3290-301. PubMed ID: 20449459
[TBL] [Abstract][Full Text] [Related]
50. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
[TBL] [Abstract][Full Text] [Related]
51. Cyanide Bridged Platinum-Iron Complexes as Cisplatin Prodrug Systems: Design and Computational Study.
Kaspi-Kaneti AW; Bhandari S; Schubert A; Huang SD; Dunietz BD
Chemphyschem; 2021 Jan; 22(1):106-111. PubMed ID: 33098742
[TBL] [Abstract][Full Text] [Related]
52. The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.
Göschl S; Varbanov HP; Theiner S; Jakupec MA; Galanski MS; Keppler BK
J Inorg Biochem; 2016 Jul; 160():264-74. PubMed ID: 27055943
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and X-ray structure analysis of cytotoxic heptacoordinate sulfonamide salan titanium(IV)-bis-chelates.
Zhao T; Grützke M; Götz KH; Druzhenko T; Huhn T
Dalton Trans; 2015 Oct; 44(37):16475-85. PubMed ID: 26325575
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations.
Song Y; Suntharalingam K; Yeung JS; Royzen M; Lippard SJ
Bioconjug Chem; 2013 Oct; 24(10):1733-40. PubMed ID: 23957697
[TBL] [Abstract][Full Text] [Related]
55. New palladium and platinum complexes with bioactive 3,5-diacetyl-1,2,4-triazol bis(4-cyclohexyl thiosemicarbazone) ligand: chemistry, antiproliferative activity and preliminary toxicity studies.
Matesanz AI; Perles J; Souza P
Dalton Trans; 2012 Oct; 41(40):12538-47. PubMed ID: 22955178
[TBL] [Abstract][Full Text] [Related]
56. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
[TBL] [Abstract][Full Text] [Related]
57. Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug.
Lee KGZ; Babak MV; Weiss A; Dyson PJ; Nowak-Sliwinska P; Montagner D; Ang WH
ChemMedChem; 2018 Jun; 13(12):1210-1217. PubMed ID: 29637702
[TBL] [Abstract][Full Text] [Related]
58. Thiolato gold(I) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties.
Vergara E; Cerrada E; Clavel C; Casini A; Laguna M
Dalton Trans; 2011 Nov; 40(41):10927-35. PubMed ID: 21904768
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
Xu Z; Chan HM; Li C; Wang Z; Tse MK; Tong Z; Zhu G
Inorg Chem; 2018 Jul; 57(14):8227-8235. PubMed ID: 29943979
[TBL] [Abstract][Full Text] [Related]
60. Bis-picolinamide Ruthenium(III) Dihalide Complexes: Dichloride-to-Diiodide Exchange Generates Single trans Isomers with High Potency and Cancer Cell Selectivity.
Basri AM; Lord RM; Allison SJ; Rodríguez-Bárzano A; Lucas SJ; Janeway FD; Shepherd HJ; Pask CM; Phillips RM; McGowan PC
Chemistry; 2017 May; 23(26):6341-6356. PubMed ID: 28225184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
